ANZUPGO
Active Ingredient: DELGOCITINIB
Product Overview
About ANZUPGO
ANZUPGO is a prescription medication containing the active ingredient Delgocitinib, a Janus kinase (JAK) inhibitor. It is used to treat moderate to severe plaque psoriasis in adults who have had an inadequate response to previous treatments.
Key Benefits & Uses
- Treatment of moderate to severe plaque psoriasis in adults.
- Improvement in skin symptoms such as redness, scaling, and thickening.
- Reduction in the severity of psoriatic lesions.
Active Ingredient & Action
Delgocitinib works by inhibiting the activity of Janus kinases (JAKs), which are enzymes involved in the signaling pathways that lead to inflammation and immune response. By blocking these enzymes, Delgocitinib reduces the production of pro-inflammatory cytokines and other mediators that contribute to psoriasis symptoms.
Important Notes
ANZUPGO is available by prescription only and should be used under the guidance of a healthcare professional. Common side effects may include headache, fatigue, and injection site reactions. Patients with a history of hepatitis B or C, or those taking immunosuppressive medications, should use ANZUPGO with caution. Consult the product label or consult with a healthcare professional for more information.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.